Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucose

Primary Care Diabetes

Volumn 7, Issue 4, 2013, Pages 309-313

  Ylitalo, Kelly R ^a,b   Herman, William H ^a,b   Harlow, Siobán D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Monofilament testing; Peripheralneuropathy; Symptoms

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NERVE FIBER MEMBRANE CONDUCTANCE; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SMALL FIBER NEUROPATHY;

MONOFILAMENT TESTING; PERIPHERAL NEUROPATHY; SYMPTOMS;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETIC NEUROPATHIES; FEMALE; HUMANS; LOGISTIC MODELS; MICHIGAN; MIDDLE AGED; NEUROLOGIC EXAMINATION; ODDS RATIO; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SENSORY THRESHOLDS; TOES;

EID: 84893765540     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2013.07.001     Document Type: Article

References (24)

1. J.G. Katon, G.E. Reiber, K.M. Nelson, Peripheral neuropathy defined by monofilament insensitivity and diabetes status: NHANES 1999-2004, Diabetes Care (2012 December) (Epub ahead of print).
2. P.J. Dyck, V.M. Clark, C.J. Overland, et al., Impaired glycemia and diabetic polyneuropathy: the OC IG survey, Diabetes Care 35 (2012) 584-591.
3. K. Pourhamidi, L.B. Dahlin, E. Englund, O. Rolandsson, No difference in small or large nerve fiber function between individuals with normal glucose tolerance and impaired glucose tolerance, Diabetes Care 36 (2013) 962-964.
4. M.A. Singer, S.A. Vernino, G.I. Wolfe, Idiopathic neuropathy: new paradigms, new promise, JPNS 17 (2012) S43-S49.
5. N. Papanas, A.I. Vinik, D. Ziegler, Neuropathy in prediabetes: does the clock start ticking early? Nat. Rev. Endocrinol. 7 (2011) 682-690.
6. A.G. Smith, Impaired glucose tolerance and the metabolic syndrome in idiopathic neuropathy, JPNS 17 (2012) S15-S21.
7. M.F. Sowers, S. Crawford, B. Sternfeld, et al., SWAN: a multi-center, multi-ethnic, community-based cohort study of women and the menopause, in: R. Lobo, J. Kelsey, R. Marcus (Eds.), Menopause: Biology and Pathobiology, Academic Press, San Diego, 2000, pp. 175-178.
8. M.J. Mueller, Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments, Phys. Ther. 76 (1996) 68-71.
9. E.L. Feldman, M.J. Stevens, P.K. Thomas, et al., A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy, Diabetes Care 17 (1994) 1281-1289.
10. E.E.K. Nang, C.M. Khoo, E.S. Tai, et al., Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease? The Singapore prospective study program, Am. J. Epidemiol. 169 (2009) 1454-1462.
11. E.L. Feldman, M.J. Stevens, Clinical testing in diabetic peripheral neuropathy, Can. J. Neurol. Sci. 21 (1994) S3-S7
12. W.H. Herman, R. Pop-Busui, B.H. Braffett, et al., Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications, Diabet. Med. 29 (2012) 937-944.
13. D. Lacomis, Small-fiber neuropathy, Muscle Nerve 26 (2002) 173-188
14. E. Hoitsma, J.P. Reulen, M. de Baets, et al., Small fiber neuropathy: a common and important clinical disorder, J. Neurol. Sci. 227 (2004) 119-130.
15. G. Devigili, V. Tugnoli, P. Penza, et al., The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology, Brain 131 (2008) 1912-1925.
16. J. Tavee, L. Zhou, Small fiber neuropathy: a burning problem, Cleve. Clin. J. Med. 76 (2009) 297-305.
17. E.W. Gregg, P. Sorlie, R. Paulose-Ram, et al., Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey, Diabetes Care 27 (2004) 1591-1597.
18. E.W. Gregg, Q. Gu, D. Williams, et al., Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among US adults aged 40 or older, Diab. Res. Clin. Pract. 77 (2007) 485-488.
19. D. Ziegler, W. Rathmann, T. Dickhaus, et al., Neuropathic pain in diabetes, prediabetes, and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3, Pain Med. 10 (2009) 393-400.
20. M. Smieja, D.L. Hunt, D. Edelman, et al., Clinical examination for the detection of protective sensation in the feet of diabetic patients, J. Gen. Intern. Med. 14 (1999) 418-424.
21. Y.J. Cheng, E.W. Gregg, H.S. Kahn, et al., Peripheral insensate neuropathy - a tall problem for US adults? Am. J. Epidemiol. 164 (2006) 873-880.
22. K.R. Ylitalo, M.F. Sowers, S. Heeringa, Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity, Diabetes Care 34 (2011) 1642-1647.
23. B. Callaghan, R. McCammon, K. Kerber, et al., Tests and expenditures in the initial evaluation of peripheral neuropathy, Arch. Intern. Med. 172 (2012) 127-132.
24. A. Gordon, Smith, Diagnosis of neuropathy: comment on "Tests and expenditures in the initial evaluation of peripheral neuropathy", Arch. Intern. Med. 172 (2012) 132-133.